Empaglifozin in Early Diabetic Kidney Disease
Clinical trial NCT03173963 · WITHDRAWN
Trial details
- NCT number
- NCT03173963
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-27
- Primary completion
- 2020-02-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.